Broxyquinoline

Broxyquinoline

SCHEMBL261708

Oc1c(Br)cc(Br)c2cccnc12.Oc1c(Br)cc(Br)c2cccnc12.Oc1c(Br)cc(Br)c2cccnc12.[Al]

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.96
HSP90AA1 P07900 7/20 0.96
TP53 P04637 7/20 0.96
MEN1 O00255 7/20 0.96
KMT2A Q03164 7/20 0.96
HTT P42858 6/20 0.96
SMN1; SMN2 Q16637 6/20 0.96
TDP1 Q9NUW8 6/20 0.96
USP2 O75604 3/20 0.96
ALOX15 P16050 5/20 0.54
LMNA P02545 5/20 0.54
ALOX12 P18054 5/20 0.54
RAB9A P51151 4/20 0.54
CYP1A2 P05177 3/20 0.54
NPSR1 Q6W5P4 3/20 0.54
L3MBTL1 Q9Y468 3/20 0.54
CYP2D6 P10635 2/20 0.54
CYP2C19 P33261 2/20 0.54
NPC1 O15118 2/20 0.54
MPI P34949 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Broxyquinoline SCHEMBL29607319 0.98 KDM4E (1.00) KDM4EHSP90AA1TP53MEN1KMT2A
Broxyquinoline SCHEMBL115293 0.98 KDM4E (1.00) KDM4EHSP90AA1TP53MEN1KMT2A
Broxyquinoline SCHEMBL30485535 0.98 KDM4E (1.00) KDM4EHSP90AA1TP53MEN1KMT2A
Broxyquinoline SCHEMBL28536097 0.96 KDM4E (0.96) KDM4EHSP90AA1TP53MEN1KMT2A
Broxyquinoline SCHEMBL22734870 0.96 KDM4E (0.96) KDM4EHSP90AA1TP53MEN1KMT2A
Broxyquinoline SCHEMBL28909008 0.96 KDM4E (0.96) KDM4EHSP90AA1TP53MEN1KMT2A
Broxyquinoline SCHEMBL28528459 0.96 KDM4E (0.96) KDM4EHSP90AA1TP53MEN1KMT2A
Broxyquinoline SCHEMBL28500050 0.96 KDM4E (0.96) KDM4EHSP90AA1TP53MEN1KMT2A
Broxyquinoline SCHEMBL31157810 0.96 KDM4E (0.96) KDM4EHSP90AA1TP53MEN1KMT2A
Broxyquinoline SCHEMBL27633003 0.96 KDM4E (0.96) KDM4EHSP90AA1TP53MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 679 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12349573-B2 Organic electroluminescent element, method for producing same and display device Konica Minolta, Inc. (JP) 2025-07-01 US disclosed
CN-114975818-B Inkjet recording medium for organic semiconductor device and member for organic semiconductor device 柯尼卡美能达株式会社 2025-05-06 CN disclosed
CN-114141971-B Organic electroluminescent device containing phenanthryl triarylamine compound and application thereof 江苏三月科技股份有限公司 2024-10-11 CN disclosed
CN-113937235-B Organic light-emitting diode device comprising light improvement layer and application thereof 江苏三月科技股份有限公司 2024-08-16 CN disclosed
US-11993728-B2 Composition for electronic devices, ink for electronic devices, and method for producing electronic device Konica Minolta, Inc. (JP) 2024-05-28 US disclosed
CN-117924246-A Pi conjugated compound, organic electroluminescent element material, luminescent thin film, organic electroluminescent element, display device, and lighting device 默克专利有限公司 2024-04-26 CN disclosed
US-11910628-B2 Luminescent film, organic electroluminescent element, organic material composition and method for producing organic electroluminescent element MERCK PATENT GMBH (DE) 2024-02-20 US disclosed
CN-113594376-B Blue organic electroluminescent device 江苏三月科技股份有限公司 2024-02-02 CN disclosed
CN-117396036-A Full-color organic electroluminescent display device and method for manufacturing the same 江苏三月科技股份有限公司 2024-01-12 CN disclosed
CN-111937174-B Light-emitting film, organic electroluminescent element, and method for producing same 柯尼卡美能达株式会社 2023-12-05 CN disclosed
US-6464898-B1 STABLE FLUORESCENCE CONVERSION CAPABILITY, HEAT RESISTANCE, LIGHT RESISTANCE, HIGH RESOLUTION MULTICOLOR IMAGE DISPLAY; FINE PARTICLES OF FLUORESCENT DYES DISPERSED IN A BINDER, WITH UV ABSORBENT AND A LIGHT STABILIZER IDEMITSU KOSAN CO., LTD. (JP) 2002-10-15 US disclosed
US-20020094452-A1 Organic electro-luminescent element and material of organic electro-luminescent element MERCK PATENT GMBH (DE) 2002-07-18 US disclosed
US-6420057-B1 AN ORGANIC METAL COMPLEX HAVING BOTH OF AN IONIC COORDINATE BOND FORMED BETWEEN A NITROGEN ANION AND A METAL CATION AND A COORDINATE BOND FORMED BY A NITROGEN ATOM OR A CHALCOGEN AND A METAL; EXCELLENT IN LUMINANCE KONICA CORPORATION (JP) 2002-07-16 US disclosed
EP-1191821-A1 Organic electroluminescent element and organic electroluminescent material used therefor KONICA CORPORATION (JP) 2002-03-27 EP disclosed
EP-1067165-A2 Organic electroluminescent element KONICA CORPORATION (JP) 2001-01-10 EP disclosed
US-6124024-A HAVING A SPECIFIC CONSTRUCTION IN WHICH THE OPTICAL THICKNESS FROM AN ANODE TO A CATHODE IS CONTROLLED AND THE COLOR PURITY OF THE BLUE LIGHT EMISSION IS INCREASED IDEMITSU KOSAN CO., LTD. (JP) 2000-09-26 US disclosed
EP-1013740-A2 Electroluminescent material, electroluminescent element and color conversion filter KONICA CORPORATION (JP) 2000-06-28 EP disclosed
US-5891554-A Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 1999-04-06 US disclosed
US-5500568-A ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 1996-03-19 US disclosed
EP-0605739-A1 ORGANIC EL DEVICE IDEMITSU KOSAN COMPANY LIMITED (JP) 1994-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020094452-A1 Organic electro-luminescent element and material of organic electro-luminescent element ESR2, ESR1, KCNE1 KDM4E 1011/4885HSP90AA1 4524/4885TP53 2445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.